The 26.2 with DONNA Mission is to passionately produce world class events to raise funds for ground breaking breast cancer research and women living with breast cancer.
Join us Marathon Weekend: Feb 12 - Feb 14, 2016. Learn more
Our 2016 Spectator Guide is now available for you to download!
Find out where the best spots are along the route to see your runner.
Learn about transportation, parking and shuttle service.
Sign up for Race Joy tracking.
Preview the Marathon Weekend – Schedule of Events.
Read More >>
TapImmune, Inc. (TPIV), a clinical-stage onco-immunology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today presented new data at the San Antonio Breast Cancer Symposium in the poster titled, “Robust generation of T-cell immunity to HER2 in HER2+ breast cancer patients with a degenerate subdominant HLA-DR epitope vaccine.” Read More >>
Jacksonville, November 5, 2015: TapImmune Inc., (OTCMKTS: TPIV) a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today that it has relocated its corporate headquarters from Seattle, Washington, to Jacksonville, Florida, located at 50 North Laura Street, Suite 2500, Jacksonville, Florida 32202. Read More >>
In the October issue of Women’s Running Magazine, WR readers voted 26.2 with DONNA their single favorite charity race. We are honored and we love you too! Race with us and find out why we readers picked us. Are you registered? WR October Issue 262 with DONNA page (PDF)